> Caraco Pharmaceutical Laboratories got the FDA's tentative approval to sell a chewable form of the allergy med Zyrtec, whose patent expires in December. Release
> Critical Therapeutics has launched an inhalation treatment for chronic obstructive pulmonary disease. Report
> Beijing Med-Pharm is expanding its senior management team with a new vice president Yanping Zhao, who will oversee all the company's Chinese subsidiaries and handle corporate strategy such as mergers and acquisitions. Report
> Coley Pharmaceutical Group has adopted a shareholder rights plan to protect itself from hostile takeover, saying the plan wasn't prompted by any current takeover attempt. Release
> Jazz Pharmaceuticals added Kohlberg Kravis Roberts & Co. Principal Nathaniel Zilkha to its board. Release
And Finally... What's in a drug name? Oh, $200,000 to $500,000 in consulting costs. Report